A Deep Learning Approach for the Identification of the Molecular Subtypes of Pancreatic Ductal Adenocarcinoma Based on Whole Slide Pathology Images.

Journal: The American journal of pathology
Published Date:

Abstract

Delayed diagnosis and treatment resistance result in high pancreatic ductal adenocarcinoma (PDAC) mortality rates. Identifying molecular subtypes can improve treatment, but current methods are costly and time-consuming. In this study, deep learning models were used to identify histologic features that classify PDAC molecular subtypes based on routine hematoxylin-eosin-stained histopathologic slides. A total of 97 histopathology slides associated with resectable PDAC from The Cancer Genome Atlas project were used to train a deep learning model and test the performance on 44 needle biopsy material (110 slides) from a local annotated patient cohort. The model achieved balanced accuracy of 96.19% and 83.03% in identifying the classical and basal subtypes of PDAC in The Cancer Genome Atlas and the local cohort, respectively. This study provides a promising method to cost-effectively and rapidly classify PDAC molecular subtypes based on routine hematoxylin-eosin-stained slides, potentially leading to more effective clinical management of this disease.

Authors

  • Pouya Ahmadvand
    School of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
  • Hossein Farahani
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • David Farnell
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
  • Amirali Darbandsari
    Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada.
  • James Topham
    Pancreas Centre BC, Vancouver, British Columbia, Canada.
  • Joanna Karasinska
    Pancreas Centre BC, Vancouver, British Columbia, Canada.
  • Jessica Nelson
    Department of Urology, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390, USA.
  • Julia Naso
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Steven J M Jones
    Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
  • Daniel Renouf
    Division of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.
  • David F Schaeffer
    Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Ali Bashashati
    Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.